IF
TAK icon

Ironwood Financial’s Takeda Pharmaceutical TAK Stock Holding History

Ironwood Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed – – 489
2021
Q3 		$0 Hold
20
– – ﹤0.01% 597
2021
Q2 		$0 Hold
20
– – ﹤0.01% 584
2021
Q1 		$0 Hold
20
– – ﹤0.01% 567
2020
Q4 		$0 Hold
20
– – ﹤0.01% 501
2020
Q3 		$0 Hold
20
– – ﹤0.01% 452
2020
Q2 		$0 Hold
20
– – ﹤0.01% 428
2020
Q1 		$0 Hold
20
– – ﹤0.01% 404
2019
Q4 		$0 Hold
20
– – ﹤0.01% 394
2019
Q3 		$0 Hold
20
– – ﹤0.01% 398
2019
Q2 		$0 Hold
20
– – ﹤0.01% 391
2019
Q1 		$0 Buy
+20
New +$402 ﹤0.01% 386

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ironwood Financial's TAK Position: Q4 2021 in Review

Ironwood Financial sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 20 shares.

Ironwood Financial first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $0 in Q3 2021. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Ironwood Financial reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 20 Takeda Pharmaceutical shares in Q4 2021.
  • Ironwood Financial first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
  • Ironwood Financial's Takeda Pharmaceutical position peaked at $0 in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.